“If you have ovarian cancer, ask your oncologistto consider a test that will help determine whether your cancer is one of just under 50 per cent that might be responsive to new treatment options such as PARPinhibitors.” That’s the message from ovarian cancer researcher Professor Anna deFazio from The Westmead Institute for Medical Research (WIMR)…